CAMBRIDGE, Mass., April 28, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer ...
SGH surveys completed over seventeen gold targets across Trillium Gold's 39,300 hectare Confederation Belt properties in the Red Lake Mining District Several significant gold probability anomalies ...
Pfizer has agreed to acquire Trillium Therapeutics for $2.26 billion, the companies said today, in a deal designed to bolster the buyer’s oncology drug portfolio by adding Trillium’s two lead ...
VANCOUVER, BC , Dec. 31, 2020 /CNW/ - Trillium Gold Mines Inc. (TSXV:TGM ) ("Trillium" or the "Company") is pleased to provide a corporate update on the year's activities in Red Lake District of ...
CAMBRIDGE, Mass., April 28, 2021 (GLOBE NEWSWIRE) — Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, ...
VANCOUVER, BC, Jan. 11, 2022 /PRNewswire/ - Trillium Gold Mines Inc. (TSXV: TGM) (OTCQX: TGLDF) (FRA: 0702) ("Trillium Gold" or the "Company") is pleased to report findings from the spaciotemporal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback